Mavor Meaghan E, Groome Patti A, Asai Yuka, Langley Hugh, Look Hong Nicole J, Wright Frances C, Hanna Timothy P
Division of Cancer Care and Epidemiology, Sinclair Cancer Research Institute, Queen's University, Kingston, Ontario, Canada
Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
BMJ Open. 2025 Jan 30;15(1):e086140. doi: 10.1136/bmjopen-2024-086140.
To characterise diagnostic pathways for patients with melanoma in routine practice and compare patient, disease and diagnostic interval (DI) characteristics across pathways.
Descriptive cross-sectional study using administrative health data.
Population-based study in Ontario, Canada.
Patients with melanoma diagnosed from 2007 to 2019.
We used latent class cluster analysis to create clusters of patients with similar diagnostic experiences to characterise diagnostic pathways in routine practice. Indicator variables characterised the patient's keratinocyte carcinoma and dermatologist history, presentation pattern, procedure types, number of visits and procedures, and the activity on the diagnosis date. χ tests and Pearson residuals were used. We characterised clusters by the lengths of their DI, primary care subinterval and specialist care subinterval.
There were 33 371 patients diagnosed with melanoma from 2007 to 2019. We identified four diagnostic pathways: 'primary care only' (n=6107), 'referred to specialist with immediate action' (n=8987), 'multiple visits and procedures in specialist care' (n=11 893) and 'specialist care only' (n=6384). Patient, disease and DI characteristics varied across pathways. Pathway types varied regionally. A higher proportion in the 'primary care only' pathway lived in rural areas whereas a higher proportion in the 'referred to specialist for immediate action' and the 'specialist care only' pathways lived in major urban centres. Across pathways, the median DI varied from 1 to 67 days, the median primary care subinterval varied from 1 to 30 days and the median specialist care subinterval varied from 1 to 25 days. Patients in the 'primary care only' pathway experienced the shortest DIs, and patients in the 'multiple visits and procedures in specialist care' pathway experienced the longest DIs.
We identified four melanoma diagnostic pathways. The shortest DI, the 'primary care only' pathway, highlights the important role of primary care and the need to reduce the wait for specialists. Diagnostic processes varied across geographical locations. Future research should address reasons for these differences, including whether they are associated with inefficient or inappropriate care.
描述黑色素瘤患者在常规医疗实践中的诊断途径,并比较各途径中患者、疾病及诊断间隔(DI)的特征。
利用行政卫生数据进行描述性横断面研究。
加拿大安大略省基于人群的研究。
2007年至2019年诊断为黑色素瘤的患者。
我们使用潜在类别聚类分析来创建具有相似诊断经历的患者聚类,以描述常规医疗实践中的诊断途径。指标变量描述了患者的角质形成细胞癌和皮肤科医生病史、就诊模式、手术类型、就诊和手术次数以及诊断日期的活动情况。使用χ检验和Pearson残差。我们通过DI长度、初级保健子间隔和专科护理子间隔的长度来描述聚类。
2007年至2019年有33371例患者被诊断为黑色素瘤。我们确定了四种诊断途径:“仅初级保健”(n = 6107)、“立即转诊至专科医生”(n = 8987)、“专科护理中多次就诊和手术”(n = 11893)和“仅专科护理”(n = 6384)。患者、疾病和DI特征因途径而异。途径类型存在地区差异。“仅初级保健”途径中较高比例的患者居住在农村地区,而“立即转诊至专科医生”和“仅专科护理”途径中较高比例的患者居住在主要城市中心。各途径中,DI中位数从1天到67天不等,初级保健子间隔中位数从1天到30天不等,专科护理子间隔中位数从1天到25天不等。“仅初级保健”途径的患者DI最短,“专科护理中多次就诊和手术”途径的患者DI最长。
我们确定了四种黑色素瘤诊断途径。最短的DI,即“仅初级保健”途径,突出了初级保健的重要作用以及减少等待专科医生时间的必要性。诊断过程因地理位置而异。未来的研究应探讨这些差异的原因,包括它们是否与低效或不适当的护理有关。